Vaccine credited with HPV virus reduction in Scotland

Apr 07, 2017, 01:22
Vaccine credited with HPV virus reduction in Scotland

Nearly 23% of adults (ages 18 to 59) in the United States are affected by high-risk genital Human Papillomavirus (HPV) that can cause cancer during a two-year period from 2013 to 2014, according to the latest report released by the Centers for Disease Control and Prevention (CDC). The same disparities also were found among those groups: Asians had the lowest rates and blacks had the highest rates. Overall, men had higher rates of both oral and genital HPV than women.

"We tend to overlook the fact that 20 percent of us are carrying the virus that can cause cancer". If that statistic seems alarming, that's because it is - especially given the fact that the HPV vaccine has been proven to be successful.

The CDC recommends that children receive the HPV vaccine around age 11 or 12 so that they become protected before potential exposure to the virus through sexual contact.

A VACCINATION campaign has led to a massive reduction in levels of the cancer-causing human papillomavirus (HPV) in Scottish women, new research shows. All girls and boys aged 11 or 12 should get the recommended three-dose series of HPV vaccine, the CDC advises.

"The next step is to increase awareness of the high prevalence of high-risk genital and oral HPV in our general USA population so individuals will realize that this is a serious problem and they will get their children vaccinated in early adolescence before they become sexually active", McQuillan said.

They found around 0.5% of women from the 1995 group tested positive for HPV 16/18, compared with 21.4% of women born before 1990.

Body-camera maker offers 1-year trial to police agencies
In addition to the name change, the company will be providing free support to police department across the United States. So they're changing their name to Axon , after the division aimed at expanding the company's technology platform.

According to Fred Wyand, spokesman for the American Sexual Health Association, "These data are a further confirmation that HPV deserves its moniker as the "common cold" of sexually transmitted infections". "The way [the vaccine] was introduced in Australia and the United Kingdom was as a cancer vaccine, which is truly what it is". According to the findings, 7.3 percent reported cases of oral HPV between 2011 and 2014.

We already know that Human Papillomavirus (HPV) is very, very common.

"This is a vaccine against cancer", CDC senior epidemiologist Geraldine McQuillan, who strongly advocates for children to be vaccinated before adolescence, said in a statement.

There a body of misconceptions and fears that could be producing the stagnation of the vaccination rates among the young says Electra Paskett, a cancer control researcher at The Ohio State University Comprehensive Cancer Center.

The prevalence of high-risk HPV among women in the new report is higher than it was in some previous studies, in part because the new report included women who were ages 18 to 59 years old in 2013 to 2014, which means they most likely were not vaccinated against HPV, McQuillan said.